Phase
Condition
Cataplexy
Dyskinesias
Cerebral Palsy
Treatment
Trihexyphenidyl
Clinical Study ID
Ages 5-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ages 5-17 years of age
Diagnosis of cerebral palsy and dystonia causing interference
Parent/legal guardian of a child with a diagnosis of cerebral palsy and dystonia
Parent/legal guardian is willing and able to provide informed permission/assent forthe study
Exclusion
Exclusion Criteria:
Previously or currently taking trihexyphenidyl
Patients turning 18 years of age within the study period (16 weeks from Study Day 1)
A language barrier for the patient that precludes communication and/or the abilityto complete study-related requirements
Study Design
Study Description
Connect with a study center
Children's Mercy Hospital Kansas City
Kansas City, Missouri 64108
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.